Results 181 to 190 of about 15,914 (251)

The Selective Personalized Radioimmunotherapy for Locally Advanced NSCLC Trial (SPRINT): Patient-Reported Outcomes [PDF]

N. Ohri, S. Jolly, Benjamin T. Cooper, R. Kabarriti, W.R. Bodner, C. Guha, S. Viswanathan, E. Shum, J.K. Sabari, Hao Cheng, R. Gucalp, Enrico Castellucci, A. Qin, S.M. Gadgeel, B. Halmos   +14 more
openalex   +1 more source

Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8⁺ T cell depletion. [PDF]

Front Med (Lausanne)
Frank C, Allen KJH, Dawicki W, Levin MC, Dadachova E.   +4 more
europepmc   +1 more source

A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer. [PDF]

Front Oncol
Zhu Z, Zan Y, Jiang M, Zhang R, Chen D, Dong G.   +5 more
europepmc   +1 more source

PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a ¹⁷⁷Lu-labeled αPD-L1 antibody

, 2020
Jingyun Ren, Mengxin Xu, Junyi Chen, Jie Ding, Peipei Wang, Li Huo, Fang Li, Zhibo Liu   +7 more
openalex   +1 more source

Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition. [PDF]

Biomolecules
Fujimura T, Muto Y, Asano Y.
europepmc   +1 more source

Treatment planning for molecular radiotherapy: potential and prospects [PDF]

, 2017
Aldridge, Matt, Bacher, Klaus, Brans, Boudewijn, Chiesa, Carlo, Cicone, Francesco, Gabina, Pablo Minguez, Gleisner, Katarina Sjogreen, Kobe, Carsten, Konijnenberg, Mark, Paphiti, Maria, Sandstrom, Mattias, Solny, Pavel, Spezi, Emiliano, Tipping, Jill, Wissmeyer, Michael   +14 more
core  

Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and ¹⁷⁷Lu-based Radioimmunotherapy of Lung Cancer. [PDF]

Nanotheranostics
Kurniawan A, Mahendra I, Rizaludin A, Utama MS, Lesmana R, Ayuningtyas FD, Dewanti MR, Syarif DG, Febrian MB.   +8 more
europepmc   +1 more source

Current landscape and clinical progress of targeted alpha radioimmunotherapy. [PDF]

Am J Nucl Med Mol Imaging
Booth OC, Dhamecha KR, Oderinde OM, Zheng QH.   +3 more
europepmc   +1 more source

Use of Integrated SPECT/CT Imaging for Tumor Dosimetry in I-131 Radioimmunotherapy: A Pilot Patient Study

, 2009
Yuni K. Dewaraja, S.J. Wilderman, Kenneth F. Koral, Mark Kaminski, Anca M. Avram   +4 more
openalex   +1 more source

At-211-anti-CD45 radioimmunotherapy as conditioning prior to haploidentical hematopoietic cell transplantation in mouse models [PDF]

Francesca K. Gaerlan, Shannon L. Dexter, Donald K. Hamlin, Yawen Li, Johnnie J. Orozco   +4 more
openalex   +1 more source